Call it venture philanthropy with a twist: If all goes as planned, the Juvenile Diabetes Research Foundation will co-own a series of companies dedicated to type 1 diabetes treatments without violating tax code, thanks to a structure created by Boston’s PureTech Ventures.
As venture firms flee early-stage risk and big companies slash research budgets, nonprofit disease foundations have tried to help turn biomedical discoveries into products, pitching in for industry research programs. Now there’s a new twist: The high-profile and well-funded Juvenile Diabetes Research Foundation wants to build new companies.
The New York-based foundation is putting up to $5 million into ownership of a holding company dubbed T1D Innovations that...
Dexcom’s CEO Kevin Sayer discusses this fall’s planned launch of the 15-day G7 CGM, downplays Abbott’s dual-sensor while focusing on development of multi-analyte G8, making OTC Stelo app more “consumerish” for Europeans, and more.
“The Corsano wearable strengthens Medtronic’s acute care and monitoring portfolio,” Marc De Martini, vice president at Medtronic, told Medtech Insight.
As the EU tests the feasibility of a radical “all-in-one” procedure for combined drug and IVD studies, sponsors are being urged to approach this novel framework with flexibility and openness.
